微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[29] 发布: 2013/07/30 16:35:23
PharmaTimes Currently, pharmacists are particularly reporting shortages of Eli Lilly's antidepressant/fibromyalgia treatment Cymbalta (duloxetine) and Pfizer's Lyrica ( pregabalin ), used in epilepsy, fibromyalgia and neuropathic pain, among other products. The IPU ... and more »
已读[29] 发布: 2013/07/30 16:34:38
RedOrbit Pregabalin can also be used to treat GAD; it limits the discharge of neurotransmitters. These, among other psychotropic and non-psychotropic drugs can be used to manage GAD. Also, the simple elimination of caffeine can remarkably reduce the severity ...
已读[35] 发布: 2013/07/30 16:34:28
ProHealth Median daily dose at the start of follow-up was 25mg for amitriptyline, 60mg for duloxetine, 300mg for gabapentin, and 75mg for pregabalin and more than 60% of patients remained on the same dose throughout the follow-up period. Only one fifth of ...
已读[58] 发布: 2013/07/30 16:34:09
The Pharma Letter Doing rather better was Lyrica ( pregabalin ), for epilepsy, fibromyalgia and neuropathic pain, which increased 10% to $1.13 billion, while the kidney cancer treatment Sutent (sunitinib) slipped 2% to $312 million. The COX-2 inhibitor Celebrex (celecoxib ... and more »
已读[58] 发布: 2013/07/30 16:33:58
PharmaTimes Lyrica ( pregabalin ), for epilepsy, fibromyalgia and neuropathic pain, increased 10% to $1.13 billion, while the kidney cancer treatment Sutent (sunitinib) slipped 2% to $312 million. The COX-2 inhibitor Celebrex (celecoxib) rose 8% to $715 million. As ... and more »
已读[39] 发布: 2013/07/30 16:33:46
ProHealth Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin . By Philip J. Mease, et al. Abstract: OBJECTIVE: To ...
已读[28] 发布: 2013/07/30 16:33:29
Healio The patients initiated therapy with pregabalin (n=378; 67.2% women) or gabapentin (n=193; 54.4% women) from 2006 to 2008. Health care resource utilization and costs from a third-payer perspective for a 1-year period after initiation were used for ...
已读[37] 发布: 2013/07/13 23:42:05
新京报讯 (记者潘波)近日,SFDA批准其在国内一些医院的皮肤科或神经科进行一项关于药物名字为普瑞巴林的临床试验,以进一步验证它在带状疱疹后神经痛的疗效。 记者...
已读[68] 发布: 2013/07/13 23:42:01
普瑞巴林是唯一被批准用于中枢和外周神经病理性疼痛的药物,可以有效缓解脑卒中后神经痛,同时还可以改善患者睡眠质量。近年来,运动皮层电刺激术逐渐开始用于治疗这类疼痛...
已读[94] 发布: 2013/07/13 23:41:57
13-14年三大重磅新品度洛西汀、阿立哌唑、普瑞巴林的获批将为公司打造麻醉线以外的第二座金矿。目前市场研究并不充分,本报告着重于此,建议投资者着重关注精神领域...
« 上一页  |   查看结果31-40共139   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘